samedan logo
 
 
spacer
home > pmps > summer 2019 > a seamless supply
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

A Seamless Supply

Clinical trials can vary in their scope and design and can be either single-site or multi-site, happening in a single country or in several geographical areas. In some clinical areas, studies are becoming larger and more complex, while the sponsors desire faster recruitment and data generation. Multi-site, multi-country studies are challenging as they require the coordination of many different parameters such as manufacturing, packaging, temperature management, storage, and distribution.

Clinical trials usually comprise three different stages: the study preparation, the active study (between ‘first patient, first visit’ and ‘last patient, last visit’) and the finalisation of the study (after ‘last patient, last visit’). Each of these stages will face different challenges of the logistics and supply chain that must be controlled.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Celine Chanforan graduated with a Masters in Food Science from the University of Montpellier, France, in 2006, and achieved her PhD in Food Chemistry from the University of Avignon, France, in 2010. Celine started her career as Project Manager in the food ingredient sector for nine years. Celine mainly managed R&D projects for food colours and dietary supplements. After moving to the UK in 2016, Celine has been in charge of projects related to the delivery of new immunoassay tests for various applications and in accordance with in vitro diagnostic quality management system ISO 13485. In 2017, Celine joined Onorach as Clinical Project Manager and is now in charge of the international clinical project portfolio.
spacer
Celine Chanforan
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Sanofi invests $180 million equity in Owkin’s artificial intelligence and federated learning to advance oncology pipeline

Sanofi announced today an equity investment of $180 million and a new strategic collaboration with Owkin comprised of discovery and development programmes in four exclusive types of cancer, with a total payment of $90 million for three years plus additional research milestone-based payments.
More info >>

White Papers

Syringe siliconization

Gerresheimer AG

Ready-to-fill, i.e. sterile, prefillable glass syringes, are washed, siliconized, sterilized and packaged by the primary packaging manufacturer. They can then be filled by the pharmaceutical companies without any further processing. These days the majority of prefillable syringes are made of glass and the trend looks set to continue. The siliconization of the syringe barrel is an extremely important aspect of the production of sterile, prefillable glass syringes because the functional interaction of the glass barrel siliconization and the plunger stopper siliconization is crucial to the efficiency of the entire system. Both inadequate and excessive siliconization can cause problems in this connection. The use of modern technology can achieve an extremely uniform distribution of silicone oil in glass syringes with reduced quantities of silicone oil. Another option for minimizing the amount of free silicone oil in a syringe is the thermal fixation of the silicone oil on the glass surface in a process called baked-on siliconization. Plastic-based silicone oil-free or low-silicone oil prefillable syringe systems are a relatively new development. Silicone oil-free lubricant coatings for syringes are also currently in the development phase.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement